Potential clinical application of interleukin-27 as an antitumor agent.
about
Expanding Diversity in Molecular Structures and Functions of the IL-6/IL-12 Heterodimeric Cytokine FamilyCirculating low IL-23: IL-35 cytokine ratio promotes progression associated with poor prognosisin breast cancerAn IL-27/Stat3 axis induces expression of programmed cell death 1 ligands (PD-L1/2) on infiltrating macrophages in lymphoma.Dual Roles of IL-27 in Cancer Biology and Immunotherapy.Regulation of myelopoiesis by proinflammatory cytokines in infectious diseases.LYG1 exerts antitumor function through promoting the activation, proliferation, and function of CD4+ T cells.Association between IL-27 gene polymorphisms and risk of papillary thyroid carcinoma.Association of IL-27 rs153109 and rs17855750 Polymorphisms with Risk and Response to Therapy in Acute Lymphoblastic Leukemia.Role of interleukin-32 in cancer biology.IL-27 gene therapy induces depletion of Tregs and enhances the efficacy of cancer immunotherapy.Polycationic carbosilane dendrimer decreases angiogenesis and tumor-associated macrophages in tumor-bearing mice
P2860
Q28075849-47694EAF-B6A0-4132-8380-B1135E36A092Q36964158-700823D1-2D42-4649-830C-6DD275424CD9Q38749945-28DB981C-F2FB-493D-8953-7ADCE360A8C1Q39158943-2DAADB3B-8C6D-4693-9428-DCF36CD270ECQ48018788-B2BCABE4-7309-4F0C-9BD8-BD92A84E63F7Q50642148-282F7029-D82F-4C74-8DD0-6087F4D761A2Q51279715-E4E8A5F1-8E72-4EF8-A5F8-F1A3C2E51254Q53725899-D0C79860-35E0-4C32-A413-77F2E19728D5Q55264916-1ADFE8A7-B12D-4DCB-BD47-188A0961AA4EQ55300547-EF4431D7-6C95-4094-AFBC-519B83A1D3C3Q57079914-C773554F-FFD9-49F4-BA75-39710ED32860
P2860
Potential clinical application of interleukin-27 as an antitumor agent.
description
2015 nî lūn-bûn
@nan
2015 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Potential clinical application of interleukin-27 as an antitumor agent.
@ast
Potential clinical application of interleukin-27 as an antitumor agent.
@en
Potential clinical application of interleukin-27 as an antitumor agent.
@nl
type
label
Potential clinical application of interleukin-27 as an antitumor agent.
@ast
Potential clinical application of interleukin-27 as an antitumor agent.
@en
Potential clinical application of interleukin-27 as an antitumor agent.
@nl
prefLabel
Potential clinical application of interleukin-27 as an antitumor agent.
@ast
Potential clinical application of interleukin-27 as an antitumor agent.
@en
Potential clinical application of interleukin-27 as an antitumor agent.
@nl
P2093
P2860
P356
P1433
P1476
Potential clinical application of interleukin-27 as an antitumor agent.
@en
P2093
Izuru Mizoguchi
Jun-Ichi Furusawa
Kaname Higuchi
Ren Tsunoda
Takayuki Yoshimoto
Yukino Chiba
P2860
P304
P356
10.1111/CAS.12731
P5008
P577
2015-07-01T00:00:00Z
2015-09-01T00:00:00Z